perform
experi
determin
effect
pkr
activ
respiratori
syncyti
viru
rsv
replic
first
determin
rsv
infect
activ
pkr
induc
phosphoryl
result
format
host
stress
granul
use
rna
interfer
decreas
endogen
pkr
level
rsv
replic
alter
cell
defici
pkr
express
howev
rsvmediat
stress
granul
format
significantli
reduc
pkrknockdown
cell
altern
method
block
pkr
activ
use
treatment
kinas
inhibitor
observ
treatment
significantli
reduc
viral
replic
also
treat
pkrknockdown
cell
inocul
rsv
condit
treatment
diminish
viral
replic
absenc
pkr
express
result
suggest
pkr
activ
minim
effect
rsv
replic
antivir
effect
rsv
infect
like
occur
via
pkrindepend
mechan
respiratori
syncyti
viru
rsv
infect
lead
caus
seriou
viral
lower
respiratori
tract
ill
infant
elderli
worldwid
rsv
member
paramyxovirida
famili
belong
pneumovirina
subfamili
rsv
genom
consist
singlestrand
negativesens
rna
molecul
encod
protein
viral
nucleoprotein
n
phosphoprotein
p
larg
polymeras
protein
l
make
ribonucleoprotein
complex
necessari
viral
transcript
replic
replic
complex
protein
found
along
genom
viral
rna
discret
cytoplasm
granul
often
term
viral
inclus
bodi
garcia
et
al
carromeu
et
al
lindquist
et
al
inclus
bodi
thought
repres
site
viral
replic
transcript
viral
protein
like
occur
immedi
entri
host
cell
detect
replic
viral
genom
appear
begin
sever
hour
inocul
follow
accumul
suffici
amount
viral
protein
transit
occur
rsv
replic
program
one
domin
transcript
viral
gene
one
replic
fulllength
genom
predomin
case
negativesens
singlestrand
rna
virus
replic
occur
viru
must
first
make
fulllength
antigenom
intermedi
rna
serv
templat
product
new
rna
genom
cowton
et
al
pkr
activ
doublestrand
rna
dsrna
viral
infect
often
associ
antivir
host
cell
respons
upon
bind
dsrna
pkr
dimer
autophosphoryl
result
activ
protein
phosphoryl
pkr
one
four
known
kinas
regul
activ
translat
initi
factor
eukaryot
initi
factor
also
includ
pkrlike
erloc
kinas
perk
hemeregul
inhibitor
hri
kinas
gener
control
nonrepress
kinas
upon
bind
activ
pkr
phosphoryl
serin
phosphoryl
incap
deliv
initi
mettrna
host
translat
complex
result
reduct
protein
synthesi
virusinfect
cell
phosphoryl
also
lead
format
host
stress
granul
host
rna
cytoplasm
granul
contain
mrna
translat
factor
mrnabind
protein
addit
activ
pkr
also
function
activ
protein
garcia
et
al
mani
virus
deploy
mechan
prevent
pkr
activ
presum
inhibit
type
interferon
respons
ensur
host
translat
machineri
remain
suffici
activ
viral
protein
synthesi
viral
strategi
prevent
pkr
activ
includ
express
viral
product
interact
directli
pkr
prevent
activ
express
viral
protein
bind
sequest
dsrna
activ
host
protein
inhibit
counteract
pkr
activ
garcia
et
al
virtual
everi
case
studi
date
activ
pkr
virusinfect
cell
associ
induct
antivir
state
howev
activ
pkr
hepat
c
viru
hcv
infect
may
enhanc
viral
replic
result
lack
synthesi
specif
antivir
interferonstimul
gene
product
infect
garaigorta
chisari
rsv
infect
lead
increas
level
total
pkr
cell
infect
groskreutz
et
al
rsv
infect
also
induc
phosphoryl
activ
pkr
groskreutz
et
al
studi
suggest
direct
interact
pkr
rsv
nucleoprotein
n
current
studi
sought
determin
function
role
pkr
express
activ
respons
rsv
infect
use
two
wellestablish
method
pkr
inhibit
data
reveal
previous
defin
pkr
chemic
inhibitor
reduc
rsv
replic
unexpectedli
pkr
protein
knockdown
shrna
affect
rsv
replic
howev
observ
drastic
decreas
stress
granul
format
pkrknockdown
cell
result
suggest
pkr
express
activ
littl
effect
rsv
replic
cultur
cell
pkr
inhibitor
like
inhibit
rsv
replic
manner
independ
pkr
rsv
infect
potent
induc
stress
granul
format
lindquist
et
al
sought
determin
mechan
fig
pkr
phosphoryl
rsv
infect
cell
infect
rsv
moi
pfucel
indic
time
fix
process
immunofluoresc
antirsv
p
monoclon
antibodi
use
local
viral
protein
appear
green
merg
panel
antibodi
use
detect
stress
granul
format
appear
red
merg
panel
phosphoryl
appear
blue
merg
panel
b
cell
mockinocul
inocul
rsv
moi
pfucel
h
cell
lysat
analyz
immunoblot
gapdh
rsv
p
phosphoryl
pkr
total
pkr
rel
protein
densiti
compar
rsvinfect
cell
mockinfect
cell
quantifi
use
licor
odyssey
imag
softwar
rsv
initi
process
typic
stress
granul
form
follow
induct
one
mani
type
stressrel
pathway
result
common
downstream
event
phosphoryl
translat
initi
factor
kedersha
anderson
therefor
examin
cell
inocul
rsv
moi
pfucel
presenc
phosphoryl
use
indirect
immunofluoresc
observ
strike
increas
phosphoryl
begin
h
postinocul
concomit
appear
stress
granul
continu
throughout
infect
fig
next
sought
determin
mechan
rsv
mediat
phosphoryl
four
welldefin
kinas
capabl
phosphoryl
protein
kinas
rna
pkr
kinas
activ
doublestrand
rna
pkrlike
erloc
kinas
perk
gener
control
nonrepress
hemeregul
inhibitor
kinas
hri
proud
reason
pkr
like
respons
phosphoryl
rsv
infect
known
rsv
infect
activ
pkr
groskreutz
et
al
cell
inocul
rsv
moi
pfucel
h
observ
phosphoryl
pkr
higher
express
total
pkr
comparison
mockinocul
cell
fig
consist
previou
report
investig
effect
inhibit
pkr
signal
might
rsv
replic
cell
transduc
shrna
lentivir
construct
specif
pkr
nontarget
shrna
control
select
cell
stabli
express
shrna
construct
compar
pkr
level
immunoblot
wildtyp
cell
transduc
cell
transduc
pkrtarget
nontarget
shrna
cell
express
pkr
shrna
construct
exhibit
approxim
decreas
total
pkr
protein
level
fig
comparison
wildtyp
cell
express
nontarget
shrna
wildtyp
nontarget
pkrknockdown
cell
inocul
rsv
moi
pfucel
incub
h
immunoblot
analysi
cell
lysat
demonstr
increas
pkr
phosphoryl
rsvinocul
pkrknockdown
cell
comparison
wildtyp
nontarget
shrna
cell
next
quantifi
viral
titer
time
cours
cell
type
cell
inocul
rsv
moi
pfucel
incub
day
cellassoci
viru
harvest
time
point
titer
determin
plaqu
assay
viral
titer
pkrknockdown
cell
differ
significantli
either
wildtyp
cell
nontarget
shrnaexpress
cell
fig
result
indic
inhibit
pkr
activ
affect
rsv
replic
next
determin
whether
pkr
kinas
respons
stress
granul
format
rsv
infect
infect
wildtyp
shrna
nontarget
pkrknockdown
cell
rsv
h
moi
pfucel
examin
cell
presenc
stress
granul
use
indirect
immunofluoresc
fig
wildtyp
shrna
nontarget
cell
observ
robust
stress
granul
format
infect
cell
howev
pkrknockdown
cell
stress
granul
format
substanti
diminish
quantifi
number
rsvinfect
cell
form
stress
granul
cell
type
result
show
approxim
infect
wildtyp
shrna
nontarget
cell
form
stress
granul
stress
granul
form
infect
pkrknockdown
cell
fig
cell
type
treat
sodium
arsenit
drug
induc
stress
granul
via
hri
kinas
rather
pkr
observ
equival
frequenc
stress
granul
format
data
shown
result
confirm
pkr
requir
stress
granul
format
follow
rsv
infect
confirm
pkr
activ
dispens
rsv
replic
sought
anoth
method
inhibit
activ
kinas
nucleotid
analog
prevent
pkr
activ
hu
conway
first
test
whether
treatment
alter
rsvmediat
pkr
activ
epitheli
cell
pretreat
mm
vehicl
h
inocul
cell
rsv
moi
pfucel
presenc
vehicl
control
h
inoculum
remov
replac
medium
contain
vehicl
infect
allow
proceed
h
cell
lysat
harvest
immunoblot
assess
level
total
phosphoryl
pkr
phosphoryl
pkr
rsvinfect
cell
treat
greatli
reduc
comparison
vehicletr
cell
fig
addit
observ
increas
total
pkr
level
presenc
occur
rsv
infect
follow
viru
inocul
control
compar
vehicletr
cell
absenc
infect
found
chang
level
pkr
phosphoryl
pkr
result
indic
inhibit
pkr
activ
rsv
infect
next
assess
effect
treatment
viral
protein
express
use
immunoblot
assay
rsv
p
protein
surrog
marker
rel
amount
total
pkr
phosphoryl
pkr
rsv
p
gapdh
quantifi
use
odyssey
imag
analysi
softwar
interestingli
observ
decreas
amount
rsv
p
protein
cell
comparison
vehicletr
cell
result
suggest
treatment
inhibit
viral
protein
synthesi
directli
determin
effect
treatment
rsv
infect
use
indirect
immunofluoresc
detect
viral
protein
infect
cell
cell
pretreat
vehicl
inocul
rsv
moi
pfucel
h
cell
fix
stain
rsv
f
protein
marker
infect
rsvinfect
cell
per
highpow
field
hpf
quantifi
treatment
observ
approxim
decreas
percent
cell
stain
posit
rsv
f
protein
follow
treatment
fig
c
thu
treatment
diminish
rsv
infect
determin
effect
treatment
capac
rsv
complet
infecti
cycl
cell
pretreat
vehicl
inocul
rsv
pfucel
adsorpt
inoculum
replac
medium
contain
vehicl
titer
cellassoci
viru
determin
interv
day
result
show
treatment
mediat
approxim
decreas
viral
titer
throughout
time
cours
infect
fig
determin
treatment
affect
viral
entri
cell
pretreat
inocul
rsv
moi
pfucel
inoculum
replac
medium
contain
vehicl
control
incub
day
contrast
cell
incub
throughout
infect
cell
pretreat
exhibit
chang
viral
titer
compar
vehicletr
cell
result
suggest
affect
viral
entri
rather
later
step
viral
life
cycl
determin
whether
effect
treatment
rsv
virusspecif
perform
similar
experi
use
reoviru
reoviru
replic
unaffect
pkr
knockdown
zhang
samuel
addit
reoviru
protein
inhibit
pkr
activ
competit
bind
dsrna
target
sherri
contrast
result
rsv
treatment
affect
reoviru
replic
first
h
infect
h
observ
signific
differ
viral
titer
vehicletr
cell
indic
treatment
much
less
inhibitori
reoviru
replic
comparison
effect
rsv
fig
next
test
whether
effect
viral
replic
observ
follow
treatment
requir
pkr
quantifi
effect
viral
titer
rsvinocul
wildtyp
nontarget
shrna
pkrknockdown
cell
treat
vehicl
cell
inocul
rsv
moi
pfucel
incub
day
cell
collect
time
point
titer
cellassoci
viru
determin
plaqu
assay
treatment
cell
mediat
reduct
viral
titer
throughout
time
cours
fig
remark
inhibit
rsv
replic
cell
type
regardless
whether
pkr
express
induc
next
treat
wildtyp
nontarget
shrna
pkrknockdown
cell
vehicl
inocul
cell
rsv
moi
pfucel
follow
incub
h
harvest
cell
lysat
use
immunoblot
detect
total
pkr
phosphoryl
pkr
rsv
p
result
show
inhibit
rsv
p
product
cell
type
independ
pkr
level
fig
taken
togeth
data
indic
inhibit
pkr
activ
affect
rsv
replic
furthermor
decreas
rsv
replic
appear
mediat
via
pkrindepend
mechan
sinc
rsv
induc
express
activ
pkr
hypothes
activ
dsrna
detector
would
mediat
antivir
effect
rsv
infect
surprisingli
found
knockdown
pkr
protein
level
affect
rsv
replic
howev
treatment
kinas
inhibitor
inhibit
pkr
effect
block
rsv
replic
regardless
pkr
express
pkrindepend
effect
rsv
replic
suggest
induct
pkrlike
kinas
sensit
enhanc
rsv
replic
ident
kinas
known
result
unexpect
two
main
reason
first
pkr
initi
cascad
event
result
phosphoryl
stress
granul
format
event
associ
stall
translat
initi
complex
might
expect
diminish
capac
host
cell
support
viral
replic
second
induct
pkr
often
associ
antivir
state
exampl
vesicular
stomat
viru
influenza
viru
replic
higher
titer
mice
comparison
wildtyp
mice
balachandran
et
al
similarli
mice
succumb
infect
higher
frequenc
infect
bunyamwera
viru
comparison
wildtyp
mice
streitenfeld
et
al
howev
case
pkr
minim
effect
viral
replic
sever
acut
respiratori
syndrom
coronaviru
replic
cell
lysat
analyz
immunoblot
gapdh
rsv
p
phosphoryl
pkr
total
pkr
rel
protein
densiti
quantifi
use
licor
odyssey
imag
softwar
rel
amount
rsv
p
protein
express
quantifi
cell
infect
rsv
treat
either
vehicl
protein
level
standard
rsvinfect
vehicletr
cell
rel
express
pkr
phosphoryl
pkr
quantifi
condit
compar
mockinfect
cell
treat
vehicl
b
cell
pretreat
vehicl
inocul
rsv
moi
pfucel
h
presenc
vehicl
process
immunofluoresc
antirsv
f
antibodi
use
detect
virusinfect
cell
differenti
interfer
contrast
dic
use
defin
peripheri
cell
c
percentag
cell
per
hpf
stain
posit
rsv
f
protein
imag
b
determin
error
bar
indic
sem
unaffect
cell
treat
phosphorodiamid
morpholino
oligom
specif
pkr
mrna
krahl
et
al
similarli
treatment
cell
pkr
sirna
littl
effect
adenoviru
reoviru
replic
zhang
samuel
rotaviru
protein
synthesi
roja
et
al
rift
valley
fever
viru
replic
alter
mous
embryo
fibroblast
cell
habjan
et
al
howev
pkr
effect
alway
antagonist
viral
infect
knockdown
pkr
shrna
result
significantli
decreas
hcv
rna
level
cell
treat
exogen
interferon
infect
hcv
garaigorta
chisari
interestingli
level
protein
involv
antivir
respons
increas
suggest
hcv
induc
pkr
activ
inhibit
host
translat
prevent
express
interferonstimul
gene
predict
similar
function
pkr
rsv
infect
sinc
previou
report
demonstr
treatment
lead
dosedepend
increas
product
rsvinfect
cell
hornung
et
al
although
rsv
singlestrand
rna
viru
produc
multipl
dsrna
intermedi
replic
capabl
activ
pkr
pkr
activ
like
requir
phosphoryl
subsequ
stress
granul
format
rsv
infect
lindquist
et
al
hanley
et
al
studi
report
rsv
induc
robust
pkr
activ
infect
phosphoryl
limit
groskreutz
et
al
phosphoryl
may
dampen
increas
activ
protein
phosphatas
infect
contrast
observ
extens
phosphoryl
rsv
infect
predominantli
cell
infect
rsv
stress
granul
form
fig
sinc
phosphoryl
frequent
preced
stress
granul
format
kedersha
anderson
result
surpris
given
extens
stress
granul
format
induc
rsv
lindquist
et
al
possibl
activ
suffici
revers
phosphoryl
rsvinfect
cell
form
stress
granul
experi
requir
assess
activ
cell
experi
use
pkrknockout
mice
show
rsv
rna
level
increas
infect
suggest
classic
role
pkr
antivir
molecul
pkrknockout
mice
rsv
infect
induc
lower
level
sever
cytokin
includ
rant
among
other
comparison
wildtyp
mice
result
combin
histolog
analysi
mous
lung
tissu
suggest
function
pkr
lead
enhanc
pathogenesi
rsvinfect
anim
minor
et
al
previou
data
show
rsv
replic
reduc
cell
stress
granul
format
inhibit
knockdown
stress
granulerel
rasgap
domainbind
protein
lindquist
et
al
current
studi
found
rsv
replic
unaffect
pkrknockdown
cell
similarli
defici
stress
granul
format
one
possibl
explan
discrep
knockdown
effect
addit
inhibit
stress
granul
format
thu
viral
replic
might
inhibit
altern
effect
knockdown
anoth
possibl
pkrknockdown
cell
pkr
signal
occur
prevent
activ
intrins
antivir
respons
viru
thu
potenti
provir
function
stress
granul
may
normal
requir
would
necessari
allow
viru
replic
effici
drug
cite
specif
inhibitor
pkr
activ
hu
conway
love
et
al
silva
et
al
use
number
studi
examin
role
pkr
viral
infect
howev
also
may
inhibit
activ
tumor
suppressor
genotox
stress
huang
et
al
interfer
cell
cycl
progress
andreassen
margoli
inhibit
mitogenactiv
protein
kinas
activ
thorburn
et
al
although
pkr
activ
implic
process
garcia
et
al
possibl
inhibit
multipl
kinas
result
demonstr
effici
block
pkr
activ
rsv
infect
inhibitori
effect
rsv
replic
pkrindepend
therefor
reliabl
pkrspecif
inhibitor
suspect
given
drug
mediat
nonpkrdepend
effect
defin
target
might
lend
insight
complex
perturb
occur
host
gene
function
rsv
infect
cell
lysat
subject
immunoblot
rsv
p
protein
gapdh
rel
amount
rsv
p
protein
quantifi
cell
type
compar
wildtyp
cell
treat
vehicl
error
bar
indic
standard
deviat
cell
atcc
maintain
optimem
medium
invitrogen
contain
vv
fetal
calf
serum
sigma
mm
lglutamin
mediatech
amphotericin
b
mediatech
streptomycin
mediatech
iuml
penicillin
mediatech
cell
grown
either
suspens
monolay
cultur
joklik
modifi
eagl
minim
essenti
medium
smem
lonza
contain
vv
fetal
bovin
serum
fb
invitrogen
mm
lglutamin
invitrogen
uml
penicillin
mgml
streptomycin
invitrogen
amphotericin
b
sigma
suspens
rsv
wildtyp
strain
prepar
cell
pfuml
use
infect
cell
monolay
cultur
infecti
viru
adsorb
cell
h
incub
co
follow
adsorpt
inoculum
remov
fresh
medium
ad
cell
incub
co
durat
infect
period
reoviru
strain
laboratori
stock
rsv
plaqu
assay
cellassoci
viru
harvest
indic
time
scrape
infect
cell
cultur
monolay
ml
medium
viru
releas
harvest
cell
describ
utley
et
al
viral
titer
determin
use
plaqu
assay
describ
murphi
et
al
reoviru
titer
determin
plaqu
assay
use
cell
reovirusinfect
cell
scrape
medium
frozen
thaw
room
temperatur
twice
prior
determin
viral
titer
suspens
plaqu
assay
virgin
et
al
reoviru
yield
calcul
accord
follow
formula
log
yield
log
pfucel
log
pfucel
time
postinfect
time
inocul
absorpt
gener
mm
stock
solut
sigma
dilut
phosphatebuff
salin
pb
glacial
acet
acid
fisher
glacial
acet
acid
dilut
ratio
pb
use
solut
incub
resuspens
cell
pretreat
mm
dilut
medium
mocktreat
vehicl
glacial
acet
acid
pb
cell
infect
rsv
presenc
mm
vehicl
h
follow
infect
inoculum
remov
replac
fresh
medium
contain
mm
vehicl
incub
durat
infect
cell
fix
wv
formaldehyd
pb
min
room
temperatur
cell
permeabil
wv
triton
paraformaldehyd
pb
min
room
temperatur
follow
fixat
cell
block
wv
bsa
pb
h
follow
addit
primari
antibodi
h
cell
wash
three
time
pb
speciesspecif
igg
alexa
fluor
molecular
probe
ad
dilut
block
solut
detect
primari
antibodi
cell
wash
time
pb
fix
glass
slide
use
prolong
antifad
kit
molecular
probe
imag
obtain
use
zeiss
invert
confoc
microscop
equip
planneofluar
oil
object
len
polyclon
antibodi
obtain
santa
cruz
use
immunostain
monoclon
antiphosphoryl
antipkr
antibodi
obtain
epitom
antirsv
f
protein
human
mous
monoclon
antibodi
palivizumab
medimmun
use
identifi
rsv
f
protein
antirsv
p
protein
clone
monoclon
antibodi
kind
gift
ewa
bjorl
earl
norrbi
shrna
reagent
lentivir
shrna
particl
obtain
dharmacon
human
gapdh
nontarget
control
set
three
pkr
smartvector
shrna
construct
cell
plate
plate
transduc
individu
lentivir
construct
accord
manufactur
protocol
select
target
cell
contain
integr
lentiviru
sequenc
select
use
puromycin
ml
dilut
medium
medium
contain
puromycin
replac
everi
day
resist
coloni
observ
cell
grown
plate
harvest
protein
cell
lyse
use
lysi
buffer
mm
trishcl
mm
nacl
triton
ph
contain
vv
proteas
inhibitor
cocktail
sigma
vv
phosphatas
inhibitor
sigma
lysat
separ
nupag
bistri
gel
invitrogen
transfer
nitrocellulos
membran
use
iblot
dryblot
system
invitrogen
membran
block
h
use
odyssey
block
buffer
licor
dilut
pb
primari
antibodi
dilut
block
buffer
incub
overnight
membran
wash
four
time
tri
buffer
salin
tween
tbst
min
licor
irdy
irdy
secondari
antibodi
dilut
block
buffer
ad
membran
h
membran
wash
four
time
tbst
band
imag
quantifi
use
odyssey
infrar
imag
system
total
pkr
phosphoryl
pkr
detect
use
monoclon
antibodi
epitom
respect
gapdh
detect
use
monoclon
antibodi
millipor
